OVERSEA CHINESE BANKING Corp Ltd Trims Stake in Xylem Inc. (NYSE:XYL)

OVERSEA CHINESE BANKING Corp Ltd decreased its position in Xylem Inc. (NYSE:XYL - Free Report) by 15.3% during the 3rd quarter, according to its most recent filing with the SEC. The institutional investor owned 203,244 shares of the industrial products company's stock after selling 36,758 shares during the period. OVERSEA CHINESE BANKING Corp Ltd owned about 0.08% of Xylem worth $27,444,000 as of its most recent filing with the SEC.

Other institutional investors have also recently bought and sold shares of the company. Swedbank AB increased its holdings in shares of Xylem by 22.8% during the 3rd quarter. Swedbank AB now owns 2,991,583 shares of the industrial products company's stock worth $403,953,000 after acquiring an additional 554,609 shares during the last quarter. Mirova US LLC lifted its position in shares of Xylem by 2.0% during the 2nd quarter. Mirova US LLC now owns 1,876,618 shares of the industrial products company's stock valued at $254,526,000 after acquiring an additional 36,013 shares during the period. Impax Asset Management Group plc lifted its position in shares of Xylem by 1.0% during the 3rd quarter. Impax Asset Management Group plc now owns 1,677,816 shares of the industrial products company's stock valued at $226,555,000 after acquiring an additional 15,825 shares during the period. DekaBank Deutsche Girozentrale lifted its position in shares of Xylem by 2.2% during the 2nd quarter. DekaBank Deutsche Girozentrale now owns 1,665,090 shares of the industrial products company's stock valued at $227,364,000 after acquiring an additional 36,601 shares during the period. Finally, Dimensional Fund Advisors LP lifted its position in shares of Xylem by 8.3% during the 2nd quarter. Dimensional Fund Advisors LP now owns 1,474,033 shares of the industrial products company's stock worth $199,930,000 after buying an additional 113,571 shares during the last quarter. Institutional investors own 87.96% of the company's stock.

Xylem Stock Performance

Xylem stock traded up $0.41 during mid-day trading on Tuesday, reaching $125.04. 1,132,554 shares of the company's stock were exchanged, compared to its average volume of 1,191,605. The company has a quick ratio of 1.42, a current ratio of 1.96 and a debt-to-equity ratio of 0.19. The business's fifty day simple moving average is $131.21 and its 200 day simple moving average is $134.99. Xylem Inc. has a one year low of $98.21 and a one year high of $146.08. The firm has a market capitalization of $30.38 billion, a PE ratio of 36.64, a P/E/G ratio of 2.29 and a beta of 1.05.

Xylem (NYSE:XYL - Get Free Report) last announced its quarterly earnings results on Thursday, October 31st. The industrial products company reported $1.11 earnings per share for the quarter, meeting the consensus estimate of $1.11. Xylem had a return on equity of 9.61% and a net margin of 9.85%. The company had revenue of $2.10 billion during the quarter, compared to analysts' expectations of $2.17 billion. During the same period in the previous year, the business earned $0.99 earnings per share. The firm's quarterly revenue was up .2% compared to the same quarter last year. On average, sell-side analysts expect that Xylem Inc. will post 4.23 earnings per share for the current year.

Xylem Dividend Announcement

The company also recently declared a quarterly dividend, which was paid on Thursday, September 26th. Shareholders of record on Thursday, August 29th were paid a dividend of $0.36 per share. This represents a $1.44 annualized dividend and a yield of 1.15%. The ex-dividend date was Thursday, August 29th. Xylem's dividend payout ratio (DPR) is currently 42.11%.

Wall Street Analyst Weigh In

XYL has been the subject of several research reports. UBS Group initiated coverage on Xylem in a research report on Tuesday, August 13th. They issued a "buy" rating and a $165.00 target price for the company. Robert W. Baird decreased their price target on Xylem from $175.00 to $154.00 and set an "outperform" rating for the company in a research note on Friday, November 1st. Stifel Nicolaus raised their target price on Xylem from $170.00 to $172.00 and gave the stock a "buy" rating in a research note on Wednesday, July 31st. TD Cowen reduced their price objective on Xylem from $138.00 to $125.00 and set a "hold" rating for the company in a research note on Wednesday, November 6th. Finally, Royal Bank of Canada reduced their price objective on Xylem from $163.00 to $162.00 and set an "outperform" rating for the company in a research note on Friday, November 1st. Four equities research analysts have rated the stock with a hold rating and nine have given a buy rating to the company's stock. According to MarketBeat.com, the company currently has an average rating of "Moderate Buy" and a consensus price target of $147.17.

Xylem Profile

Xylem Inc, together with its subsidiaries, engages in the design, manufacture, and servicing of engineered products and solutions worldwide. It operates through four segments: Water Infrastructure, Applied Water, Measurement & Control Solutions, and Integrated Solutions and Services. The Water Infrastructure segment offers products, including water, storm water, and wastewater pumps; controls and systems; filtration, disinfection, and biological treatment equipment; and mobile dewatering equipment and rental services under the ADI, Flygt, Godwin, Sanitaire, Magneto, Neptune Benson, Ionpure, Leopold, Wedeco, and Xylem Vue brands.